An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Name: An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Published: 2015
License: Public Domain

Alexion Pharmaceuticals, Inc. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

relapse

neuromyelitis optica, neuromyelitis optica spectrum disorder, long-term safety study, extension trial, eculizumab, devic's disease, transverse myelitis, optic neuritis, relapse, nmo-igg, cns autoimmune disorders, demyelinating disorders

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 871567
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.